No Recommendation for Inpatient Inherited Thrombophilia Testing

Share this content:
No Recommendation for Inpatient Inherited Thrombophilia Testing
No Recommendation for Inpatient Inherited Thrombophilia Testing

MONDAY, Nov. 7, 2016 (HealthDay News) -- Inpatient assessment for inherited thrombophilia is not recommended, according to a review published in the November issue of the Journal of Hospital Medicine.

Noting that about 7 percent of the population has inherited thrombophilia, which predisposes to an increased risk of venous thromboembolism (VTE), and that patients with inherited thrombophilia have a three- to 20-fold increased relative risk of VTE, Christopher M. Petrilli, M.D., from the University of Michigan in Ann Arbor, and colleagues examined the value of inpatient inherited thrombophilia testing.

The researchers report that the current evidence recommends against testing for inherited thrombophilia in most clinical settings. Thrombophilia results do not change management in patients without a personal history of VTE, as there is no evidence to support thromboprophylaxis in this setting. Inpatient testing is not indicated in patients with a personal history of provoked or unprovoked VTE, as results do not influence management. Furthermore, testing is not cost-effective. A positive result may trigger unnecessary patient anxiety or involvement of consultants. Because many thrombophilia tests are inaccurate in the setting of acute VTE and/or anticoagulation, testing in hospitalized patients has even more limitations.

"Inpatient evaluation for inherited thrombophilia for VTE is not clinically useful, cost-effective, or reliable in the setting of VTE," the authors write. "The result of such testing does not affect management of acute primary or recurrent VTE."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-C-Section Cephalexin, Metronidazole Cuts SSI Rate

Post-op course reduces rate of surgical site infection within 30 days of C-section among obese women

Multicomponent Intervention Linked to Greater Drop in BP

Multicomponent Intervention Linked to Greater Drop in BP

Intervention beneficial over 18 months for low-income adults in Argentina with uncontrolled HTN

Total of 0.21 Years Lost Due to Opioid-Related Poisoning Deaths

Total of 0.21 Years Lost Due to Opioid-Related ...

Drug-related poisoning deaths up from 2000 to 2015, with most of the increase due to opioid deaths

is free, fast, and customized just for you!

Already a member?

Sign In Now »